Quantitative determination of betamethasone and its major metabolite in equine urine by micro-liquid chromatography-mass spectrometry.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Analytical Methods
- Biochemistry
- Corticosteroids
- Diagnosis
- Diagnostic Technique
- Disease Diagnosis
- Equine Diseases
- Equine Health
- High-performance Liquid Chromatography (HPLC)
- Horses
- Laboratory Methods
- Metabolism
- Metabolites
- Pharmaceuticals
- Pharmacokinetics
- Steroids
- Urine Analysis
- Veterinary Medicine
- Veterinary Research
- Veterinary Science
Summary
This research examined the effectiveness of using micro-liquid chromatography-mass spectrometry (micro-LC-MS) to measure levels of the drug betamethasone and its main derivative in horse urine and blood samples. The study argues that this method is superior to a more traditional testing method for these compounds.
Introduction and Aim
In this study, the researchers aimed at examining the potential of a method known as micro-liquid chromatography-mass spectrometry (micro-LC-MS) to decipher the quantity of a drug and its major metabolite in biological fluids of horses, specifically plasma and urine.
The drug in focus was betamethasone, a corticosteroid administered for inflammatory conditions. The major metabolite of this drug, 6 beta-hydroxybetamethasone, is the chemical compound produced when betamethasone is broken down in the horse’s body and excreted in its urine.
Methodology and Advantages
- The method the researchers used was micro-LC-MS, a highly advanced and sensitive laboratory tool used in detecting the presence of particular biological molecules in a sample.
- This method proved advantageous over the traditional gas chromatography-mass spectrometry (GC-MS) method generally employed for these tests. GC-MS requires a harsher process for sample preparation, may not always yield a comprehensive profile of all metabolites, and could cause the degradation of analytes due to high temperatures utilized.
- On the other hand, micro-LC-MS is presented as a less rigorous method that could detect lower limits of compound concentrations and provide a detailed profile of metabolites.
Research Outcomes
- The research outcome was the validation of the micro-LC-MS as an efficient, reliable method in detecting the presence and quantifying betamethasone and its main metabolite in equine biological fluids.
- This could be highly useful for the monitoring and regulation of drug use in equine sports and can aid in attaining a fair competition environment.
- The successful application of micro-LC-MS in this context can potentially pave the way to apply the method for several other substances and in similar contexts where low limits of detection and higher sensitivity are required.
Cite This Article
Publication
Researcher Affiliations
MeSH Terms
- Animals
- Betamethasone / analogs & derivatives
- Betamethasone / blood
- Betamethasone / urine
- Chromatography, Liquid / methods
- Chromatography, Thin Layer
- Horses / blood
- Horses / urine
- Mass Spectrometry / methods
- Plasma / analysis